Assessing The Likely Cost-Utility Of Alemtuzumab Versus Rabbit Anti-Thymocte Globulin As Induction Therapy For High-Risk Kidney Transplant Recipients
Tung, A, Devine, E., Garrison, L.Volume:
17
Langue:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2014.03.1709
Date:
May, 2014
Fichier:
PDF, 63 KB
english, 2014